Anorexia nervosa is a growing concern in mental health, often inducing death. The potential neuronal deficits that may underlie abnormal inhibitions of food intake, however, remain largely unexplored. We hypothesized that anorexia may involve altered signaling events within the nucleus accumbens (NAc), a brain structure involved in reward. We show here that direct stimulation of serotonin (5-hydroxytryptamine, 5-HT) 4 receptors (5-HT4R) in the NAc reduces the physiological drive to eat and increases CART (cocaine-and amphetamine-regulated transcript) mRNA levels in fed and food-deprived mice. It further shows that injecting 5-HT4R antagonist or siRNA-mediated 5-HT4R knockdown into the NAc induced hyperphagia only in fed mice. This hyperphagia was not associated with changes in CART mRNA expression in the NAc in fed and food-deprived mice. Results include that 5-HT4R control CART mRNA expression into the NAc via a cAMP/PKA signaling pathway. Considering that CART may interfere with food-and drug-related rewards, we tested whether the appetite suppressant properties of 3,4-N-methylenedioxymethamphetamine (MDMA, ecstasy) involve the 5-HT4R. Using 5-HT4R knockout mice, we demonstrate that 5-HT4R are required for the anorectic effect of MDMA as well as for the MDMA-induced enhancement of CART mRNA expression in the NAc. Directly injecting CART peptide or CART siRNA into the NAc reduces or increases food consumption, respectively. Finally, stimulating 5-HT4R-and MDMA-induced anorexia were both reduced by injecting CART siRNA into the NAc. Collectively, these results demonstrate that 5-HT4R-mediated upregulation of CART in the NAc triggers the appetite-suppressant effects of ecstasy.
Anorexia nervosa is a growing concern in mental health, often inducing death. The potential neuronal deficits that may underlie abnormal inhibitions of food intake, however, remain largely unexplored. We hypothesized that anorexia may involve altered signaling events within the nucleus accumbens (NAc), a brain structure involved in reward. We show here that direct stimulation of serotonin ( A norexia nervosa is one of the mental diseases exhibiting the highest mortality rates in industrialized countries (1, 2) . No effective strategies for treating this disorder are available. If one defines anorexia as self-imposed deprivation despite an energy demand, similar behavior can be provoked by treatments that increase serotonin (5-hydroxytryptamine, 5-HT) neuromodulation (3) . For instance, fenf luramine, which increases synaptic 5-HT levels, lowers the consumption of food in humans and rodents (4, 5) . Similarly, amphetamine and 3,4-N-methylenedioxymethamphetamine (MDMA, ecstasy) diminish food consumption in humans (6) and rats (7) and reduce deprivation-induced eating in mice (8) . 5-HTinduced hypophagia is mediated by both 5-HT 1B and 5-HT 2C receptors (5-HT 1B R and 5-HT 2C R) (9 -11) . In particular, 5-HT 2C R in the hypothalamus contributes to fenf luramineand MDMA-induced anorexia-like behavior (5, 8, 12) . Moreover, 5-HT 1B R and 5-HT 2C R knockout (KO) mice are less sensitive to fenf luramine (4, 5) .
Stress and anxiety can also induce anorexia (13) , and increases in 5-HT neuromodulation are known to participate in the decreased food intake caused by stress (14) (15) (16) . We have demonstrated that 5-HT 4 R KO displays attenuated responses to stress-induced hypophagia (17) . Because MDMA is a rewarding drug that reduces the intake of food despite an energy demand (8) , mimicking anorexia-like behavior, we reasoned that the activation of 5-HT 4 R into the nucleus accumbens (NAc) may be essential for MDMA-induced anorexia. Indeed, the NAc, as a brain reward center, may influence the physiological drive to eat (18) (19) (20) (21) , which also contains high densities of 5-HT 4 R (22).
To address this possibility, we examined the effects on food intake of directly stimulating or inactivating 5-HT 4 R in the NAc, and we also investigated whether these receptors are further involved in the anorectic effect of MDMA by using a combination of pharmacological, biochemical, immunocytochemical, and molecular biology techniques that include intracerebral injection of siRNA-mediated 5-HT 4 R (si5-HT 4 R) knockdown into the NAc. Using 5-HT 4 R KO mice, we further determined that 5-HT 4 R contribute to the appetite-suppressant effect of MDMA. Additional experiments revealed that the activation of accumbal 5-HT 4 R increases the mRNA level of the satiety factor cocaine-and amphetamine-regulated transcript (CART) via a cAMP/PKA signaling pathway. Finally, we provide evidence that increased CART mRNA expression mediates the appetitesuppressant effects of both accumbal 5-HT 4 R stimulation and MDMA, the psychogenic compound of ecstasy.
Results

Stimulation of Accumbal 5-HT4R Inhibits Food Intake and Increases the
Level of CART mRNA. Food intake was measured over 2 h, starting 1 h after intraaccumbal injections of NaCl or endo-N-8-methyl-
Two different doses of BIMU8 reduced food intake in both fed (42-46%, Fig. 1A ) and food-deprived mice (27-33%, Fig. 1C ). As expected, no significant effect of BIMU8 (4 ϫ 10 Ϫ4 g/l) was observed in food-deprived 5-HT 4 R KO [total food intake in g: wild type (WT), 0.58 Ϯ 0.05; KO, 0.60 Ϯ 0.06 (mean Ϯ SEM)]. BIMU8-induced hypophagia is then mediated specifically by the activation of 5-HT 4 R.
The animals used in the experiments presented in Fig. 1 A and C were killed 3 h after the injections and the levels of CART mRNA determined in the NAc. The levels of CART mRNA were higher in the BIMU8-injected than in the NaCl-treated mice. Both doses of BIMU8 induced increases in CART mRNA levels in both fed (57-58%, Fig. 1B ) and food-deprived (67-56%, Fig. 1D ) mice. In neither group were changes in CART mRNA levels observed in the hypothalamus (data not shown). Fig. 1 A) , but not in food-deprived mice (Fig. 1C ). To further demonstrate that 5-HT 4 R into the NAc regulates food intake, we performed a knockdown of 5-HT 4 R into the NAc, using siRNA. Infusing si5-HT 4 R into the NAc reduced the level of both 5-HT 4 R mRNA over 6 h (Fig. 1E ) and binding sites in the NAc (Fig. 1F) . As well as RS39604, injecting si5-HT 4 R into the NAc increased food intake in fed (ϩ89% vs. si5-HT 4 R control, ϩ92% vs. NaCl, Fig.  1 A) and not in food-deprived mice (Fig. 1C ) compared with controls. In all groups, there were no changes in CART mRNA levels observed in the NAc ( Fig. 1 B and D) and the hypothalamus (data not shown).
Intracellular Signaling Events Involved in 5-HT4R-Induced CART mRNA
Expression. We hypothesized that the observed 5-HT 4 R-mediated up-regulation of CART mRNA expression in the NAc may involve the G s /cAMP/PKA pathway for two reasons. First, stimulating 5-HT 4 R in cultured neurons induces the production of cAMP and the activation of PKA (23) . Second, forskolin, an adenylyl cyclase activator, increases CART mRNA levels in the NAc (24) . Injecting BIMU8 into the NAc potently activated cAMP production in this brain structure, compared with saline-injected mice ( Fig. 2A ). This increase was not detected when BIMU8 was combined with N-(2-[p-bromocinnamylamino]ethyl)-5-isoquinoline-sulfonamide hydrochloride (H89) (Fig. 2B ), used at a dose of 2 g/l, which inhibits the PKA-and forskolin-induced increase in accumbal CART mRNA levels (24) . compared the appetite-suppressant effects of i.p. injections of MDMA in food-deprived WT or 5-HT 4 R KO mice. We found that the appetite-suppressant effect of MDMA was weaker in 5-HT 4 R KO mice than in WT mice 1 h after the MDMA injection (Fig. 3A) . By 3 h after injection, the anorectic effect of MDMA was entirely suppressed in 5-HT 4 R KO mice (Fig. 3B) .
The i.p. injection of MDMA also increased the levels of CART mRNA in the NAc of WT mice (Fig. 4) . When MDMA was injected into 5-HT 4 R KO mice, however, CART mRNA levels were the same as in saline-treated KO mice (Fig. 4) . No differences in CART mRNA expression were detected between the NAc of saline-treated mice of both genotypes (Fig. 4) . Again, CART mRNA expression was unchanged in the hypothalamus after the MDMA injection (data not shown).
Knockdown of CART in the NAc Induces Overeating in Fed Mice and
Inhibits Stimulating 5-HT4R-and MDMA-Induced Anorexia. As reported previously (25) , intraaccumbal injection of the CART 55-102 peptide reduced food deprivation-induced eating (Fig.  5) . We next examined whether CART mRNA in the NAc could mediate the anorectic effects of MDMA. For this purpose, we performed a tissue-specific knockdown of CART with siRNA (siCART).
Injecting siCART into the NAc reduced both CART mRNA and peptide levels in the NAc after 3 days (Fig. 6B and darkfield photomicrographs in B c and e). CART immunoreactivity (Ir) indicated that the peptide level was unchanged in the arcuate nucleus, but was lower in the lateral hypothalamus ( Fig. 6B d and  f ) . Injection of siCART into the NAc increased the level of food intake in fed mice compared with control mice (Fig. 6A) . To test for possible nonspecific effects of siCART, substance P-Ir was examined on serial brain sections because both peptides are colocalized in the NAc (26) . No changes in substance Pimmunolabeled fibers were detected in brain sections from siCART-treated or control mice (Fig. 6B g, i and h, j) .
In contrast to what was observed in fed mice (Fig. 6A ), no differences were observed between the food intake of fooddeprived mice receiving intraaccumbal injections of either si-CART or siCART control ( Fig. 7A and B) . In addition, siRNA knockdown of CART in the NAc abolished the appetitesuppressant effect of injected BIMU8 (Fig. 7A) . Finally, CART Data are means Ϯ SEM of total food intake in starved WT mice treated with 1 l of NaCl (n ϭ 7) or CART 55-102 at a dose of 1 g/l (n ϭ 9) or 5 g/l (n ϭ 7) or untreated (controls, n ϭ 7). Surgical manipulations did not modify feeding responses compared with mice not submitted to any surgical procedure (controls) (P ϭ 0.19). Treatments that differ significantly from saline are noted ( § §, P Ͻ 0.01; § § §, P Ͻ 0.001).
knockdown in the NAc partially restored deprivation-induced eating in mice treated with MDMA (Fig. 7B) .
Discussion
Over the last six decades, studies have demonstrated that the hypothalamus influences feeding behavior through multiple neuronal messengers, including 5-HT (11, 27) . In particular, 5-HT-induced hypophagia is known to involve the hypothalamic receptors 5-HT 1B R and 5-HT 2C R (11, 28) . At the same time, the hypothalamus is probably not the only brain structure through which 5-HT influences food intake. Although several results have suggested that the NAc is crucial for regulating feeding behavior (18) (19) (20) 29) , the involvement of specific 5-HT receptor subtypes present in this structure and involved in the modulation of feeding behavior remained to be explored fully.
This work reports one example of a 5-HT receptor subtype being expressed in the NAc, which influences the physiological drive to eat. Specifically, we observed that stimulating accumbal 5-HT 4 R diminishes the intake of food in fed mice (increased satiety) and reduces the physiological drive to eat after food deprivation. It provides a further demonstration that 5-HT reduced appetite in the NAc via the 5-HT 4 R because blocking (antagonist) or inactivating (si5-HT 4 R) accumbal 5-HT 4 R elevates food intake in fed mice (decreased satiety) but not in motivated mice (food-deprived). Results are consistent with studies indicating that 5-HT in the hypothalamus induces satiety (30) . For example, the i.p. injection of the 5-HT 2C R antagonist RS102221 does not modify food deprivation-induced eating although it increases food intake when mice are fed ad libitum (31) .
Stimulation of 5-HT 4 R also increases the levels of mRNA encoding the anorectic peptide CART in the NAc. Further, consistent with the well known coupling of adenylyl cyclase with 5-HT 4 R (23), activating 5-HT 4 R increases cAMP production and up-regulates CART mRNA expression via PKA in the NAc. These results are consistent with those of Jones and Kuhar (24), who demonstrated that the injection of forskolin increases CART mRNA levels in a cAMP/PKA pathway-dependent manner. In parallel, injecting acutely 5-HT 4 R antagonist or si5-HT 4 R did not change CART mRNA levels into the NAc, as well as observed in 5-HT 4 R KO mice. Together, these results suggest that 5-HT 4 R exert a phasic and positive control of CART mRNA expression via the cAMP/PKA pathway in the NAc.
Using siRNA technology, we found that the selective knockdown of CART in the NAc suppresses the 5-HT 4 R-mediated inhibition of deprivation-induced eating. It is noteworthy that only fed, but not food-deprived, mice consumed more food after intraaccumbal injections of siCART. This result indicates that basal CART levels in the NAc do not produce a significant anorectic effect when a positive drive to eat is reinforced (i.e., with food deprivation). Interestingly, CART peptide-Ir was lower in the lateral hypothalamus after the injection of siCART into the NAc, consistent with the possible presence of CART/ GABA neuronal projections from the NAc to the hypothalamus (25) . Therefore, we cannot exclude the possibility that the observed effects of siCART partly involve CART-expressing accumbal-hypothalamus neurons. In any case, the local presence of CART peptide within the NAc influences the consumption of food, as evidenced by the appetite-suppressant effect of intraaccumbal injection of the CART 55-102 peptide. Two additional results further support the notion that CART acts locally to control appetite within the NAc: (i) i.p. injection of MDMA Fig. 7 . MDMA-induced anorexia-like behavior in starved mice was reduced when CART was knocked down in the NAc by using siCART. Data are means Ϯ SEM of total food intake for 1 h. (A) WT mice treated with saline or BIMU8 injected alone (n ϭ 14 -14) or combined with the siCART control (n ϭ 15) or siCART (n ϭ 10) into the NAc. (B) WT mice treated with an i.p. injection of saline or MDMA plus an intraaccumbal infusion of siCART control (n ϭ 8 and 14, respectively) or siCART (n ϭ 14 and 12, respectively). Treatments that differ significantly from NaCl are noted ( §, P Ͻ 0.05; § § §, P Ͻ 0.0001). Significant differences between siCART and siCART control are marked ( * , P Ͻ 0.05; ** , P Ͻ 0.01). There was a significant interaction between both modes of injection (#, P Ͻ 0.05).
increased CART mRNA expression in the NAc, but not in the hypothalamus; and (ii) the selective knockdown of CART in the NAc diminished the inhibitory effect that i.p. injection of MDMA has on the physiological drive to eat.
The final experiment in our series bore out our hypothesis that MDMA-induced anorexia involves the activation of 5-HT 4 R in the NAc. Indeed, both anorexia and the increased levels of CART mRNA in the NAc resulting from i.p. injection of MDMA were reduced in 5-HT 4 R KO mice. The decrease in food intake that normally occurs in response to MDMA treatment was completely blocked in 5-HT 4 R KO mice 3 h after the i.p. MDMA injection. In contrast, in the 1st h after MDMA administration, the appetite-suppressant effect of the drug was only reduced in 5-HT 4 R KO mice (but not in WT mice), which suggests that there may be additional short-lasting mechanisms (e.g., 5-HT 2C R-dependent pathways, contributing to MDMA-induced anorexia; see ref. 8) .
We have shown previously that the 5-HT 4 R KO mouse is one animal model that displays decreased anorexia-like behavior in response to stress (17) . Again, the hyposensitivity of 5-HT 4 R KO mice to MDMA raises the possibility that the absence of 5-HT 4 R results in a general inadaptability to stressors, as defined previously (32) , which may include psychostimulants such as MDMA. Given the fact that stress is widely suspected to influence feeding disorders in humans, a pathology associated with anxiety and depression (13, 33) , it is conceivable that, under stress, genetic predispositions related to 5-HT 4 R and CART may be involved in feeding anomalies.
Experimental Procedures
Animals. All experiments were performed on 4-to 6-month-old male WT and 5-HT 4 R KO mice on a 129/Sv genetic background. Mice were obtained from heterozygous breeding (17) and housed (n ϭ 5 per cage) with food and water available ad libitum in a temperature-controlled environment with a 12-h light/12-h dark cycle (light onset at 0700). We performed experiments with different groups of WT and KO mice in accordance with the Guide for Care and Use of Laboratory Animals established by the Centre National de la Recherche Scientifique.
Surgery. WT mice were anesthetized by i.p. injection of ketamine (60 mg/kg) and xylasine (15 mg/kg) and placed in a stereotaxic frame (David Kopf Instruments, Tujunga, CA). Each compound used (see below) was dissolved in NaCl (9‰) and stored at 4°C until use. A sterile 26-gauge stainless steel guide was unilaterally implanted in the left-shell NAc at the following coordinates from the bregma: anterior, ϩ1.6 mm, height, Ϫ4.3 mm; lateral, ϩ0.7 mm according to the brain atlas (34) . The localization of the injection sites was systematically assessed for each mouse.
Feeding Tests and Treatments. We performed experiments using a classic feeding paradigm including (or not) food deprivation for 24 h (8). First, a series of WT mice received, in the NAc (i) an acute injection of 1 l containing NaCl (9‰), the 5-HT 4 R agonist BIMU8 (4 ϫ 10 Ϫ6 , 4 ϫ 10 Ϫ4 , 0.4 g/l; Boehringer Ingelheim, Ingelheim, Germany), the antagonist RS39604 (4 ϫ 10 Ϫ6 , 4 ϫ 10 Ϫ4 ; Tocris, Ellisville, MO), double-stranded si5-HT 4 R (0.05 g/l, mouse mRNA: sense, 5Ј-AUGAUG-GCA ACUGAUCGAC99-3Ј; antisense, 5Ј-GUCGAU-CAGUUGCCAUCAU99-3Ј), si5-HT 4 R control, or the CART 55-102 peptide (1.0 g/l; Bachem AG); (ii) a chronic injection (3 days, 1 l) of double-stranded siCART (0.05, 0.1 g/l, mouse mRNA: sense, 5Ј-CCUGAAUAGACCAUUCGCG99-3Ј; antisense, 5Ј-CGCGAAUGGUCUAUUCAGG99-3Ј) or siCART control. Both siCART and si5-HT 4 R controls (Eurogentec, San Diego, CA) contained identical nucleotides but in random order and had no significant homology with any known rodent mRNAs. Second, a series of WT and 5-HT 4 R KO mice received an i.p. injection containing a single dose of NaCl (9‰) or MDMA (10 mg/kg; Sigma, see ref. 8) . Third, WT mice were injected i.p. with a single dose of NaCl (9‰) or MDMA (10 mg/kg) combined with a chronic intraaccumbal injection of siCART, siCART control (0.1 g/l), or NaCl (9‰). Finally, another set of WT mice received, in the NAc, 1 l of BIMU8 (4 ϫ 10 Ϫ4 g/l), combined or not with siCART, siCART control (0.1 g/l), or NaCl (9‰). In the latter combined treatment experiments, animals were food-deprived for 18 h. Each compound was infused into the NAc of conscious mice at a rate of 1 l/min with a microsyringe nanopump (CE; myNeuroLab, St. Louis, MO). After a recovery period of 24 h, mice were isolated in individual metabolic cages for a baseline period of 3 days. Classic food (16.5% crude protein/3.6% crude fat/4.6% crude fiber/ 5.2% ash) was provided, as described previously (8, 17) .
Immunocytochemistry. Mice were anesthetized 3 h after the final injection of siCART or siCART control. Brains were fixed in paraformaldehyde (4%, 24 h, 4°C) and cryoprotected for 24 h in 20% (wt/vol) sucrose/0.1 M phosphate buffer (35) . Serial 30-m-thick coronal sections were labeled with a rabbit polyclonal primary antibody against CART (1/2,000; Phoenix Pharmaceuticals, St. Joseph, MO) or substance P (1/1,000; DiaSorin, Inc., Stillwater, MN) and incubated for 2 h with a goat anti-rabbit IgG conjugated to horseradish peroxidase (1/1,000; AbCys, Paris, France). An average of five to eight serial coronal sections were examined, respectively, at the levels of the NAc (anterior ϩ1.6 mm) and the hypothalamus (anterior Ϫ1.5 mm) from bregma (34) .
Receptor Autoradiography. Frozen serial coronal brain sections (12 m thick) from mice were processed for ligand-binding autoradiography of 5-HT 4 R with the antagonist 125 I-SB207710 (36, 37) . Briefly, sections were incubated in the appropriate buffer supplemented with 10 M pargyline/0.01% ascorbic acid/ 125 I-SB207710 (specific activity, 2,000 Ci/mmol; final concentration, 0.02 nM; Amersham, Piscataway, NJ) at 37°C for 30 min. Nonspecific binding was determined on consecutive sections incubated in the presence of 1 M GR113808 [SigmaAldrich, St. Louis, MO (35, 36) ]. All of the labeled sections were exposed to Kodak X-Omat Blue (PerkinElmer, Waltham, MA) for 5 days at 4°C (36, 37) . Sections from mice of both groups were processed together to obtain corresponding radiograms on the same films.
Quantitative Real-Time PCR (QR-PCR). Animals were killed 3 h after the various treatments, and the NAc (1.2 mm 3 ) and hypothalamus (2 ϫ 2.4 mm 3 ) were microdissected from 1-mm-thick sections at Ϫ20°C by using a micropunch following the landmarks of the stereotaxic atlas [NAc, anterior ϩ1.6 mm; hypothalamus, anterior ϩ0.58 and Ϫ1.58 mm, from bregma (34)]. As described (38) , total mRNA was isolated, treated with DNase, and reverse-transcribed. First-strand cDNA was used as a template for QR-PCR amplification (ABI Prism 7000; Applied Biosystems, Foster City, CA) in 10-l reactions containing a 300 nM concentration of each of the CART primers [sense and antisense primers, respectively, hybridized to nucleotides 246-269 and 296-314 of the mRNA sequence of mouse CART (NM013732)] or 5-HT4R mRNA primers [sense and antisense primers, respectively, hybridized to nucleotides 688-705 and 631-654 of the mRNA sequence of mouse 5-HT 4 R (NM008313)] and a master mix (SybR Green) including Taq polymerase. Samples were successively incubated (50°C, 2 min; 95°C, 10 min) followed by 40 cycles of denaturation (95°C, 15 s), annealing, and extension (60°C, 1 min). The size of fragments was assessed by using electrophoretic separation in nusive 3:1 agarose gel. The relative expression level of the CART gene was evaluated by QR-PCR of two housekeeping genes (aldolase 3
